Please assess the completion status of the following clinical trial:

Trial Title: Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Prior enrollment in Study B2801001 and dosing with TT-034~* An informed consent form for this study signed and dated by the subject or a legally acceptable representative~Exclusion Criteria:~* There are no specific exclusion criteria for this follow-up study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dosed subjects (Type: None): There is no intervention. This is a observational study monitoring subjects that were dosed with TT-034 in the Tacere B2801001 study,

Based on this trial design, predict the completion outcome and termination type (if applicable).